- Investing Ideas
- U.K. Pharmaceuticals & Biotech High Insider Buying
U.K. Pharmaceuticals & Biotech High Insider Buying
Results
10
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
10 companies
Haleon
Market Cap: UK£32.0b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.64
7D
-2.6%
1Y
-0.5%
Hikma Pharmaceuticals
Market Cap: UK£3.3b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.82
7D
1.3%
1Y
-21.1%
Genus
Market Cap: UK£1.4b
Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£21.36
7D
0.3%
1Y
-13.7%
Oxford Nanopore Technologies
Market Cap: UK£1.1b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.08
7D
-4.0%
1Y
-48.7%
PureTech Health
Market Cap: UK£299.4m
Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
PRTC
UK£1.23
7D
-1.6%
1Y
-13.7%
Animalcare Group
Market Cap: UK£230.3m
Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.
ANCR
UK£3.34
7D
0%
1Y
27.3%
Bioventix
Market Cap: UK£79.7m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£15.25
7D
-1.6%
1Y
-43.9%
ECO Animal Health Group
Market Cap: UK£68.4m
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.
EAH
UK£1.01
7D
15.4%
1Y
32.9%
OptiBiotix Health
Market Cap: UK£5.8m
A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.
OPTI
UK£0.056
7D
0%
1Y
-51.3%
Physiomics
Market Cap: UK£2.2m
Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.
PYC
UK£0.0047
7D
-9.5%
1Y
0%